Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fusion peptide comprising thrombus-targeting peptide, ferritin fragment and thrombolytic peptide, and use thereof

Fusion peptide comprising thrombus-targeting peptide, ferritin fragment and thrombolytic peptide, and use thereof

US Patent 11261236 · Granted Mar 1, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Time synchronization method and apparatus for low-orbit satellite cluster2025
Recombinant plasma membrane-based vesicle, for treating cancer2025
Therapeutic compounds for red blood cell-mediated delivery of an active pharmace2024
Therapeutic compounds for red blood cell-mediated delivery of an active pharmace2024
Exosome-based anticancer agent2024
Semiconductor process wastewater treatment system and semiconductor process wast2023
Exosome-based anticancer agent2022
Immunoregulatory protein-siRNA complex having anticancer activity2022
Nanocage and use thereof2021
Human-derived ferritin monomer fragment and fusion polypeptide using same2020
Human-derived ferritin monomer fragment and fusion polypeptide using same2020
Fusion polypeptide in which anti-inflammatory polypeptide and ferritin monomer f2019